share_log

Bioasis Technologies Inc. (OTCMKTS:BIOAF) Sees Large Increase in Short Interest

Defense World ·  Jan 18, 2023 18:11

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a large increase in short interest during the month of December. As of December 30th, there was short interest totalling 73,600 shares, an increase of 429.5% from the December 15th total of 13,900 shares. Based on an average daily volume of 124,100 shares, the short-interest ratio is presently 0.6 days.

Bioasis Technologies Price Performance

Shares of BIOAF stock opened at $0.04 on Wednesday. The company has a 50 day moving average of $0.08 and a 200-day moving average of $0.11. Bioasis Technologies has a 12-month low of $0.02 and a 12-month high of $0.25. The firm has a market cap of $2.90 million, a P/E ratio of -0.91 and a beta of 0.40.

Get Bioasis Technologies alerts:

Bioasis Technologies (OTCMKTS:BIOAF – Get Rating) last issued its quarterly earnings results on Friday, October 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.09 million for the quarter. As a group, equities analysts expect that Bioasis Technologies will post -0.03 EPS for the current year.

About Bioasis Technologies

(Get Rating)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases.

Featured Articles

  • Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
  • Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
  • Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
  • Can Alaska Air Continue Soaring Above The Airline Industry?
  • Insulet Has Potential To Gain More Than Analysts Are Forecasting
  • Cathie Wood Is Buying These Stocks, Should You?

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment